Basics Organon & Co.. IPO Date: May 14, 2021 Sector: Healthcare Industry: Drug Manufacturers - General Market Cap: $1.86B Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 1.67% Avg Daily Range (30 D): $0.18 | 2.59% Avg Daily Range (90 D): $0.20 | 2.24% Institutional Daily Volume Avg Daily Volume: 2.48M Avg Daily Volume (30 D): 6.69M Avg Daily Volume (90 D): 4.48M Trade Size Avg Trade Size (Sh.): 102 Avg Trade Size (Sh.) (30 D): 168 Avg Trade Size (Sh.) (90 D): 141 Institutional Trades Total Inst.Trades: 3,998 Avg Inst. Trade: $3.51M Avg Inst. Trade (30 D): $2.93M Avg Inst. Trade (90 D): $3.65M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $7.92M Avg Closing Trade (30 D): $5.45M Avg Closing Trade (90 D): $5.61M Avg Closing Volume: 407.26K     News Nov 17, 2025 @ 6:00 PM Global Contraceptive Devices Market is Set to Acce... Source: Delveinsight Nov 4, 2025 @ 7:50 PM Women’s Health Collective Canada and Partne... Source: Amy Flood Nov 4, 2025 @ 7:50 PM L’Association canadienne pour l’é... Source: Association Canadienne Pour L'Équité En Santé Des Femmes (Acesf) Oct 29, 2025 @ 5:36 PM MoonLake Immunotherapeutics (MLTX) Faces Securitie... Source: Hagens Berman Sep 15, 2025 @ 6:06 PM Women’s Health Collective Canada Launches V... Source: Daniel St. Germaine Financials   TTM Q3 2025 Q2 2025 Basic EPS $1.93 $.61 $.56 Diluted EPS $1.91 $.61 $.56 Revenue $ 6.3B $ 1.6B $ 1.59B Gross Profit $ 3.47B $ 857M $ 874M Net Income / Loss $ 501M $ 160M $ 145M Operating Income / Loss $ 702M $ 243M $ 229M Cost of Revenue $ 2.83B $ 745M $ 720M Net Cash Flow $ -91M $ 73M $ 52M PE Ratio 3.82